Burzynski Research Institute (Burzynski Research Institute) Other Operating Expense : $0.00 Mil (TTM As of Nov. 2023)

View and export this data going back to . Start your Free Trial

What is Burzynski Research Institute Other Operating Expense?

Burzynski Research Institute's Other Operating Expense for the three months ended in Nov. 2023 was $0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Nov. 2023 was $0.00 Mil.

Burzynski Research Institute's quarterly Other Operating Expense increased from May. 2023 ($-0.00 Mil) to Aug. 2023 ($0.00 Mil) but then declined from Aug. 2023 ($0.00 Mil) to Nov. 2023 ($0.00 Mil).

Burzynski Research Institute's annual Other Operating Expense declined from Feb. 2021 ($0.00 Mil) to Feb. 2022 ($-0.00 Mil) and declined from Feb. 2022 ($-0.00 Mil) to Feb. 2023 ($-0.00 Mil).

Burzynski Research Institute Other Operating Expense Historical Data

The historical data trend for Burzynski Research Institute's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Burzynski Research Institute Other Operating Expense Chart

Burzynski Research Institute Annual Data

Trend

Feb14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Other Operating Expense

Get a 7-Day Free Trial

Burzynski Research Institute Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
Other Operating Expense	Get a 7-Day Free Trial															-	-	-	-	-

Burzynski Research Institute Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Burzynski Research Institute Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Burzynski Research Institute's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Burzynski Research Institute (Burzynski Research Institute) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Burzynski Research Institute Inc (OTCPK:BZYR) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

9432 Katy Freeway, Houston, TX, USA, 77055

Website

http://www.burzynskiresearch.com

Burzynski Research Institute Inc engages in the research, production, marketing, promotion, and sale of certain medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives and organic acids which are known under the trade name Antineoplastons. Antineoplastons are used in the treatment of human cancer. Its pipeline development programs of the company include clinical trials for the treatment of a wide variety of cancers using only a combination of Antineoplastons A10 and AS2-1.

Executives

Monika Szopa-paszkowiak	director	9432 KATY FWY #200, HOUSTON TX 77055
Frederick Richard Schiff	director	9432 KATY FREEWAY, HOUSTON TX 77055
Barbara Burzynski	director, 10 percent owner	9432 KATY FREEWAY, HOUSTON TX 77055
Carlton Hazlewood	director	9432 KATY FREEWAY, HOUSTON TX 77055
Patryk Goscianski	officer: Secretary and Treasurer	9432 KATY FREEWAY, HOUSTON TX 77055
Gregory Burzynski	director	9432 KATY FREEWAY, HOUSTON TX 77055
Tomasz Janicki	officer: VP of Clinical Trials	9432 KATY FREEWAY, HOUSTON TX 77055
Michael Driscoll	director	9432 KATY FREEWAY, HOUSTON TX 77055
Stanislaw Burzynski	director, 10 percent owner, officer: President	9432 KATY FREEWAY, HOUSTON TX 77055
Dudley Reece Anderson	officer: Chief Financial Officer	9432 OLD KATY RD., SUITE 200, HOUSTON TX 77055

Burzynski Research Institute (Burzynski Research Institute) Headlines

No Headlines